Welcome

The Electrode Company

The Electrode Company

Clinical Success


The Lightman, the only device currently capable of measuring pulse oximeter sensor accuracy, is enjoying significant market uptake. Reported benefits of using The Lightman include improved oxygen therapy and improved patient outcomes.

Clinical Guidelines and protocols referencing Oxygen Saturation levels can only be followed by the use of accurate reliable pulse oximeter systems. The identification and removal from use of inaccurate pulse oximeter sensors is an essential component of Quality Assurance and Patient Safety. About a third of sensors in use have previously been found to not be fit for purpose. The Lightman now makes it possible to identify and prevent the use of these sensors thereby improving oxygen management and patient care.

The Lightman has now proven itself with consequent improvements in patient outcomes.

Who We Are


The Electrode Company Ltd. (TEC) is a completely self-financed private company wholly owned by its two founders - Dr GR Mathews and Dr VM Hickson. Both founding directors share a life-long fascination and passion for science and medicine. Our aim is to improve medical benefits and efficiencies by giving medical professionals better information for clinical decisions. We passionately believe that the first priority is to always do what is in the best interest of the patient. Our credibility comes from TEC's complete independence from pulse oximeter manufacturers and from maintaining the very best scientific and medical expertise and delivery of the highest quality service.

New standards in Pulse Oximetry


Pulse oximetry is no longer just used as a general guide to oxygenation of a patient but is an integral part of clinical assessment and monitoring. Increasingly Clinical Guidelines are recommending the use of Pulse Oximetry as a major component in assessment and management decisions.

Some say that the education of end users in the use of pulse oximetry exempts pulse oximetry from being accurate, this is not acceptable. Others believe that CE marking and FDA clearance are guaranties of sensor accuracy, this is not true. It is as if pulse oximeter sensors are an embarrassing detail that has been overlooked. Pulse oximeter system accuracy is very dependent on sensor accuracy. Sensor accuracy is dependant on the spectral properties of the sensor being correct. All too often this is not the case, putting patients at risk from inappropriate oxygen therapy.

Clinicians have come to rely on pulse oximeters. In good faith, judgements are based on the data they give. The reliability of the data depends on the accuracy of the pulse oximeter sensor. If the accuracy of the sensor is not known, every clinical decision made that is based on the data, is without foundation. The Lightman can provide this foundation.